FORT MYERS, FL (PRWEB) February 04, 2016
21st Century Oncology is proud to announce that Dr. Timothy Shafman has been appointed Senior Vice President, National Medical Director at 21st Century Oncology. Dr. Shafman is moving from Rhode Island where he served as the Medical Director of 21st Century Oncology’s New England region.
Dr. Shafman is a graduate of the Harvard Medical School in the Harvard University-Massachusetts Institute of Technology Division of Health Sciences and Technology. Following an internship in Internal Medicine at the Brigham and Women's Hospital in Boston, he completed a residency in Radiation Oncology at the Harvard Joint Center for Radiation Therapy, where he was elected Chief Resident in the final year of his training.
Dr. Shafman went on to serve as an attending physician for five years at the Harvard Joint Center for Radiation Therapy, before moving on to continue his clinical research on brain and lung tumors at the Duke University Medical Center, Department of Radiation Oncology. He has been with 21st Century Oncology since 2004, and helped establish the company’s presence in Rhode Island and Massachusetts.
“We are excited to welcome Dr. Shafman to his new role as National Medical Director. His dynamic background and years of practice will continue to be an invaluable asset to the company and the patients he serves,” said Daniel Dosoretz, M.D., President and CEO of 21st Century Oncology.
Dr. Shafman has published more than 45 peer reviewed articles and has also co-authored several chapters in widely read Radiation Oncology textbooks. In addition to serving as 21st Century Oncology’s Senior Vice President, National Medical Director, he sees patients in the company’s Port Charlotte office.
For more information visit http://www.21co.com.
About 21st Century Oncology:
21st Century Oncology is the largest global, physician led provider of Integrated Cancer Care services. The company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of September 30, 2015, the company operated 182 treatment centers, including 146 centers located in 17 states and 36 centers located in seven countries in Latin America. The company holds market-leading positions in most of its domestic local markets and abroad.